Hospital burden of pulmonary arterial hypertension in France.

by Emmanuel Bergot, Lucie De Leotoing, Hakim Bendjenana, Charlène Tournier, Alexandre Vainchtock, Gaëlle Nachbaur, Marc Humbert
Published 2019-01-01

Hospitalisation costs of metastatic melanoma in France; the MELISSA study (MELanoma In hoSpital coSts Assessment)

by Jérôme Fernandes, Bruno Bregman, Patrick Combemale, Camille Amaz, Lucie de Léotoing, Alexandre Vainchtock, Anne-Françoise Gaudin
Published 2017-08-01

Burden of pneumococcal pneumonia requiring ICU admission in France: 1-year prognosis, resources use, and costs

by Claire Dupuis, Ayman Sabra, Juliette Patrier, Gwendoline Chaize, Amine Saighi, Céline Féger, Alexandre Vainchtock, Jacques Gaillat, Jean-François Timsit
Published 2021-01-01

Access to innovative drugs for metastatic lung cancer treatment in a French nationwide cohort: the TERRITOIRE study

by Arnaud Scherpereel, Isabelle Durand-Zaleski, François-Emery Cotté, Jérôme Fernandes, Didier Debieuvre, Cécile Blein, Anne-Françoise Gaudin, Charlène Tournier, Alexandre Vainchtock, Pierre Chauvin, Pierre-Jean Souquet, Virginie Westeel, Christos Chouaïd
Published 2018-10-01

Survival inequalities in patients with lung cancer in France: A nationwide cohort study (the TERRITOIRE Study).

by Christos Chouaïd, Didier Debieuvre, Isabelle Durand-Zaleski, Jérôme Fernandes, Arnaud Scherpereel, Virginie Westeel, Cécile Blein, Anne-Françoise Gaudin, Nicolas Ozan, Soline Leblanc, Alexandre Vainchtock, Pierre Chauvin, François-Emery Cotté, Pierre-Jean Souquet
Published 2017-01-01